{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:07:57Z","timestamp":1784581677325,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.hoc.2026.05.013","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:44:46Z","timestamp":1782161086000},"page":"667-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Palliative Therapy for Liver and Biliary Neoplasms"],"prefix":"10.1016","volume":"40","author":[{"given":"Bridget N.","family":"Fahy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.hoc.2026.05.013_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non\u2013small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.hoc.2026.05.013_bib2","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1200\/JCO.2014.58.6362","article-title":"Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial","volume":"33","author":"Bakitas","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.013_bib3","first-page":"65","article-title":"Prevalence and characteristics of pain in patients with hepatocellular carcinoma: a systematic review and meta-analysis","volume":"31","author":"He","year":"2023","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.013_bib4","first-page":"463","article-title":"Clinical presentation and outcomes of patients with biliary malignancies: the Aga Khan University experience","volume":"10","author":"Kumar","year":"2009","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"17","key":"10.1016\/j.hoc.2026.05.013_bib5","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.3390\/cancers14174269","article-title":"The role of neural signaling in the pancreatic cancer microenvironment","volume":"14","author":"Takahashi","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.013_bib6","first-page":"S-164","article-title":"Early versus late celiac plexus neurolysis for pancreatic cancer: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"140","author":"Wyse","year":"2011","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.hoc.2026.05.013_bib7","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jama.291.9.1092","article-title":"Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.013_bib8","first-page":"CD007519","article-title":"Celiac plexus block for pancreatic cancer pain in adults","author":"Arcidiacono","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.013_bib9","first-page":"E403","article-title":"Comparison of different spinal level approaches in splanchnic sympathetic neurolysis for intractable upper abdominal cancer pain: a retrospective review","volume":"28","author":"Koyyalagunta","year":"2025","journal-title":"Pain Physician"},{"issue":"8","key":"10.1016\/j.hoc.2026.05.013_bib10","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S1470-2045(24)00223-7","article-title":"Celiac plexus radiosurgery for pain management in advanced cancer: a multicentre, single-arm, phase 2 trial","volume":"25","author":"Lawrence","year":"2024","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.013_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2009.11.004","article-title":"Stereotactic body radiotherapy for unresectable cholangiocarcinoma","volume":"94","author":"Kopek","year":"2010","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.013_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13014-022-02076-5","article-title":"Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review","volume":"17","author":"Vornh\u00fclz","year":"2022","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.013_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/jcrt.JCRT_836_19","article-title":"Role of intraluminal brachytherapy as a palliative treatment modality in unresectable cholangiocarcinomas","volume":"17","author":"Chigurupalli","year":"2021","journal-title":"J Cancer Res Therapeut"},{"issue":"7","key":"10.1016\/j.hoc.2026.05.013_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-097545","article-title":"STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II study","volume":"15","author":"van Loosbroek","year":"2025","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.013_bib15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jamcollsurg.2016.12.048","article-title":"Comparative efficacy of bilateral thoracoscopic splanchnicectomy for intractable pain secondary to pancreatic cancer vs chronic pancreatitis","volume":"224","author":"Bhutiani","year":"2017","journal-title":"J Am Coll Surg"},{"issue":"12","key":"10.1016\/j.hoc.2026.05.013_bib16","first-page":"1426","article-title":"Hepatic hilar nerve block for adjunctive analgesia in thermal ablation of liver tumors: a prospective randomized controlled trial","volume":"197","author":"Georgiades","year":"2025","journal-title":"R\u00f6fo"},{"issue":"suppl","key":"10.1016\/j.hoc.2026.05.013_bib17","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","article-title":"Epidemiology of hepatocellular carcinoma: consider the population","volume":"47","author":"Mittal","year":"2013","journal-title":"J Clin Gastroenterol"},{"issue":"14","key":"10.1016\/j.hoc.2026.05.013_bib18","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1200\/JCO.2004.08.141","article-title":"Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group","volume":"22","author":"Caraceni","year":"2004","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.013_bib19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.21037\/tcr-20-2692","article-title":"The efficacy of gabapentin combined with opioids for neuropathic cancer pain: a meta-analysis","volume":"10","author":"Bao","year":"2021","journal-title":"Transl Cancer Res"},{"issue":"8","key":"10.1016\/j.hoc.2026.05.013_bib20","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1080\/02656736.2018.1424946","article-title":"Randomized trial of preoperative administration of oral pregabalin for postoperative analgesia in patients scheduled for radiofrequency ablation of focal lesions in the liver","volume":"34","author":"Abdelfattah","year":"2018","journal-title":"Int J Hyperther"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.013_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/15360288.2018.1460436","article-title":"Prescribing trends of palliative care team\u2019s use of dexamethasone for cancer-related pain","volume":"32","author":"Barghi","year":"2018","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.013_bib22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12876-025-04169-3","article-title":"Efficacy of prophylactic dexamethasone in reducing post-embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"25","author":"Li","year":"2025","journal-title":"BMC Gastroenterol"},{"issue":"8550","key":"10.1016\/j.hoc.2026.05.013_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(87)92733-4","article-title":"Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice","volume":"2","author":"Speer","year":"1987","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.hoc.2026.05.013_bib24","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.gie.2005.11.052","article-title":"Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial","volume":"63","author":"Soderlund","year":"2006","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.013_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12893-024-02595-w","volume":"24","author":"Cai","year":"2024","journal-title":"BMC Surg"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.013_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jpainsymman.2013.03.013","article-title":"A meta-analysis of randomized trials: immediate stent placement vs. surgical bypass in the palliative management of malignant biliary obstruction","volume":"47","author":"Glazer","year":"2014","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.013_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/j.gastro.2023.04.016","article-title":"EUS-guided choledocho-duodenostomy using lumen apposing stent versus ERCP with covered metallic stents in patients with unresectable malignant distal biliary obstruction: a multicenter randomized controlled trial (DRA-MBO Trial)","volume":"165","author":"Teoh","year":"2023","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.hoc.2026.05.013_bib28","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1478-3231.2006.01326.x","article-title":"Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials","volume":"26","author":"Khurana","year":"2006","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.013_bib29","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","article-title":"Sertraline as a first-line treatment for cholestatic pruritus","volume":"45","author":"Mayo","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.013_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-123-3-199508010-00001","article-title":"Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial","volume":"123","author":"Bergasa","year":"1995","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.013_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/ijd.14708","article-title":"Gabapentin for uremic pruritus: a systematic review of randomized controlled trials","volume":"59","author":"Eusebio-Alpapara","year":"2020","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.hoc.2026.05.013_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2133.1987.tb05825.x","article-title":"A combination of phototherapy and cholestyramine for the relief of pruritus in primary biliary cirrhosis","volume":"116","author":"Cerio","year":"1987","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.013_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/gut.26.3.291","article-title":"Role of plasmapheresis in primary biliary cirrhosis","volume":"26","author":"Cohen","year":"1985","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.hoc.2026.05.013_bib34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamadermatol.2025.1471","article-title":"Nemolizumab for cholestatic pruritus in a patient with liver transplant and primary sclerosing cholangitis","volume":"161","author":"Soto-Canetti","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.hoc.2026.05.013_bib35","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1572-0241.2002.05852.x","article-title":"Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease","volume":"97","author":"Neff","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hoc.2026.05.013_bib36","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.2147\/DDDT.S386829","article-title":"Risk factors for HE in hepatocellular carcinoma after sorafenib or lenvatinib treatment: a real-world study","volume":"16","author":"Chen","year":"2022","journal-title":"Drug Des Dev Ther"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.013_bib37","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000159","article-title":"Psychological burden of HE on patients and caregivers","volume":"11","author":"Fabrellas","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.013_bib38","first-page":"590","article-title":"Risk of bleeding in hepatocellular carcinoma patients treated with atezolizumab\/bevacizumab: a systematic review and meta-analysis","volume":"13","author":"Song","year":"2024","journal-title":"Liver Cancer"},{"key":"10.1016\/j.hoc.2026.05.013_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003044.pub3","article-title":"Non-absorbable disaccharides versus placebo\/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis","volume":"4","author":"Gluud","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.hoc.2026.05.013_bib40","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1001\/jamainternmed.2014.4746","article-title":"Lactulose vs polyethylene glycol 3350-electrolyte solution for treatment of overt HE: the HELP randomized clinical trial","volume":"174","author":"Rahimi","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.hoc.2026.05.013_bib41","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/ajg.2013.219","article-title":"A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt HE","volume":"108","author":"Sharma","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.hoc.2026.05.013_bib42","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.hoc.2026.05.013_bib43","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.2214\/AJR.09.2968","article-title":"Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft","volume":"193","author":"Fanelli","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"13","key":"10.1016\/j.hoc.2026.05.013_bib44","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/diagnostics14131372","article-title":"Clinical implications and management of spontaneous portosystemic shunts in liver cirrhosis","volume":"14","author":"Juncu","year":"2024","journal-title":"Diagnostics"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.013_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(17)33829-5","article-title":"Embolization for closure of spontaneous porto-systemic shunts in patient with cirrhosis and refractory hepatic encephalopathy: a systematic review and meta-analysis","volume":"152","author":"Patil","year":"2017","journal-title":"Gastroenterology"},{"issue":"LB04","key":"10.1016\/j.hoc.2026.05.013_bib46","article-title":"Efficacy of albumin dialysis (MARS) in patients with cirrhosis and advanced grades of hepatic encephalopathy: a prospective, controlled, randomized multicenter trial","volume":"38","author":"Hassanein","year":"2004","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.013_bib47","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/j.ackd.2015.05.004","article-title":"Albumin dialysis for liver failure: a systematic review","volume":"22","author":"Tsipotis","year":"2015","journal-title":"Adv Chron Kidney Dis"},{"issue":"10","key":"10.1016\/j.hoc.2026.05.013_bib48","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/hpb.12474","article-title":"Spontaneous hepatic haemorrhage: a review of pathogenesis, aetiology and treatment","volume":"17","author":"Srinivasa","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"40","key":"10.1016\/j.hoc.2026.05.013_bib49","doi-asserted-by":"crossref","first-page":"14921","DOI":"10.3748\/wjg.v20.i40.14921","article-title":"Risk factor analysis of perioperative mortality after ruptured bleeding in hepatocellular carcinoma","volume":"20","author":"Lin","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.013_bib50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jviscsurg.2014.05.007","article-title":"Management of bleeding liver tumors","volume":"151","author":"Darnis","year":"2014","journal-title":"J Vis Surg"},{"issue":"10","key":"10.1016\/j.hoc.2026.05.013_bib51","doi-asserted-by":"crossref","first-page":"328","DOI":"10.14740\/jmc3064e","article-title":"Experience of palliative radiotherapy for tumor-associated bleeding from biliary tract cancer","volume":"9","author":"Kawabata","year":"2018","journal-title":"J Med Cases"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.013_bib52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12072-011-9338-z","article-title":"Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy","volume":"7","author":"Hsu","year":"2013","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.013_bib53","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"issue":"Supplement","key":"10.1016\/j.hoc.2026.05.013_bib54","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.4103\/jcrt.JCRT_606_18","article-title":"Therapeutic results of Denver percutaneous peritoneovenous shunt in cancer patients with malignant ascites","volume":"16","author":"Tamagawa","year":"2020","journal-title":"J Cancer Res Therapeut"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.013_bib55","first-page":"83","article-title":"Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer","volume":"16","author":"Sugarbaker","year":"1989","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.013_bib56","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4103\/0973-1482.176426","article-title":"Effectiveness of intraperitoneal or intrapleural administration of triamcinolone acetonide for the control of malignant ascites and pleural effusion (Kansai Clinical Oncology Group-G1102 study)","volume":"13","author":"Ito","year":"2017","journal-title":"J Cancer Res Therapeut"},{"key":"10.1016\/j.hoc.2026.05.013_bib57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejca.2016.05.004","article-title":"Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: a multicentre double-blind, placebo-controlled phase II study - AIO SUP-0108","volume":"63","author":"Jordan","year":"2016","journal-title":"Eur J Cancer"},{"issue":"22","key":"10.1016\/j.hoc.2026.05.013_bib58","doi-asserted-by":"crossref","first-page":"36707","DOI":"10.18632\/oncotarget.13543","article-title":"Intraperitoneal zivaflibercept effectively manages refractory ascites in colorectal cancer patients","volume":"8","author":"Lu","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.hoc.2026.05.013_bib59","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10147-014-0750-y","article-title":"Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites","volume":"20","author":"Ito","year":"2015","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2026.05.013_bib60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jso.25453","article-title":"Palliation of malignant ascites","volume":"120","author":"Hodge","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.hoc.2026.05.013_bib61","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920940887","article-title":"Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma","volume":"12","author":"Di Giorgio","year":"2020","journal-title":"Ther Adv Med Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2026.05.013_bib62","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/0016-5085(92)91520-E","article-title":"Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics","volume":"103","author":"Pockros","year":"1992","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.013_bib63","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/hep.1840080521","article-title":"Ascitic fluid analysis in malignancy-related ascites","volume":"8","author":"Runyon","year":"1988","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.013_bib64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jasc.2016.04.004","article-title":"A specimen volume of \u226580 mL improves cytologic sensitivity for malignant ascites: a retrospective analysis of 2665 cases","volume":"5","author":"Rooper","year":"2016","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.hoc.2026.05.013_bib65","article-title":"First-line chemotherapy in advanced biliary tract cancer ten years after the ABC-02 trial: \"and yet it moves!\"","volume":"27","author":"Rizzo","year":"2021","journal-title":"Cancer Treat Res Commun"},{"issue":"5","key":"10.1016\/j.hoc.2026.05.013_bib66","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.21037\/jgo-2025-130","article-title":"A promising model for prediction of chemotherapeutic sensitivity in gastrointestinal cancers using patient-derived malignant ascites organoids","volume":"16","author":"Yu","year":"2025","journal-title":"J Gastrointest Oncol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858826000535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858826000535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:30:18Z","timestamp":1784579418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858826000535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0889858826000535"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2026.05.013","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palliative Therapy for Liver and Biliary Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2026.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}